Vertex Pharmaceuticals, Inc (NASDAQ: VRTX) is 4.58% higher on its value in year-to-date trading and has touched a low of $377.85 and a high of $519.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VRTX stock was last observed hovering at around $432.00 in the last trading session, with the day’s loss setting it -10.84%.
Currently trading at $421.16, the stock is -10.99% and -13.29% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.06 million and changing -2.51% at the moment leaves the stock -10.30% off its SMA200. VRTX registered -0.38% loss for a year compared to 6-month loss of -18.50%.
The stock witnessed a -15.06% gain in the last 1 month and extending the period to 3 months gives it a -7.07%, and is -3.14% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.13% over the week and 2.94% over the month.
Vertex Pharmaceuticals, Inc (VRTX) has around 6100 employees, a market worth around $108.15B and $11.04B in sales. Fwd P/E is 20.16. Profit margin for the company is -8.95%. Distance from 52-week low is 11.46% and -18.99% from its 52-week high. The company has generated returns on investments over the last 12 months (-5.45%).
The EPS is expected to grow by 4182.49% this year
The shares outstanding are 256.97M, and float is at 256.04M with Short Float at 1.48%.
The top institutional shareholder in the company is CAPITAL WORLD INVESTORS with over 26.71 million shares valued at $12.52 billion. The investor’s holdings represent 10.3479 of the VRTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 22.98 million shares valued at $10.77 billion to account for 8.9018 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 21.31 million shares representing 8.2574 and valued at over $9.99 billion, while STATE STREET CORP holds 4.5432 of the shares totaling 11.73 million with a market value of $5.5 billion.
Vertex Pharmaceuticals, Inc (VRTX) Insider Activity
The most recent transaction is an insider sale by Bhatia Sangeeta N., the company’s Director. SEC filings show that Bhatia Sangeeta N. sold 400 shares of the company’s common stock on May 02 ’25 at a price of $505.86 per share for a total of $0.2 million. Following the sale, the insider now owns 4831.0 shares.
Still, SEC filings show that on Mar 13 ’25, ALTSHULER DAVID (EVP, Chief Scientific Officer) disposed off 3,231 shares at an average price of $510.00 for $1.65 million. The insider now directly holds 23,281 shares of Vertex Pharmaceuticals, Inc (VRTX).
